Needham C A
Department of Laboratory Medicine, Lahey Clinic Medical Center, Burlington, Massachusetts 01805.
Clin Microbiol Rev. 1988 Apr;1(2):218-27. doi: 10.1128/CMR.1.2.218.
Ampicillin resistance was first reported among clinical isolates of Haemophilus influenzae in 1972. Reports of chloramphenicol resistance followed shortly thereafter. The principal mechanism of resistance to these two antibiotics is enzymatic. Although other mechanisms have been described, they are found in comparatively few strains. The genetic information for the inactivating enzymes is plasmid mediated and therefore readily transmissible to susceptible strains. Consequently, effective therapy for invasive disease caused by this pathogen has been seriously compromised. As antibiotic susceptibility became less predictable, in vitro testing became increasingly important. Unfortunately, the standardization of methods for laboratory testing has been slow and complicated by the fastidious nature of the organisms. This review traces the development of antibiotic resistance in H. influenzae, discusses the mechanisms which appear to be important in mediating resistance, explores newer antimicrobial agents which might be useful in the treatment of infection, and analyzes the various approaches to in vitro testing.
1972年,首次报道了流感嗜血杆菌临床分离株对氨苄西林耐药。此后不久,又有对氯霉素耐药的报道。对这两种抗生素耐药的主要机制是酶促反应。虽然还描述了其他机制,但在相对较少的菌株中发现。使酶失活的遗传信息由质粒介导,因此很容易传播给易感菌株。因此,针对这种病原体引起的侵袭性疾病的有效治疗受到严重影响。随着抗生素敏感性变得越来越难以预测,体外试验变得越来越重要。不幸的是,由于该微生物的苛求特性,实验室检测方法的标准化进展缓慢且复杂。本综述追溯了流感嗜血杆菌抗生素耐药性的发展,讨论了在介导耐药性中似乎起重要作用的机制,探索了可能用于治疗感染的新型抗菌剂,并分析了体外试验的各种方法。